Xeris Pharmaceuticals (XERS)
(Real Time Quote from BATS)
$2.37 USD
+0.01 (0.21%)
Updated Jul 22, 2024 11:52 AM ET
2-Buy of 5 2
D Value F Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/13/24 |
---|---|
Current Quarter | -0.11 |
EPS Last Quarter | -0.14 |
Last EPS Surprise | -16.67% |
ABR | 1.00 |
Earnings ESP
|
-3.77% |
---|---|
Current Year | -0.39 |
Next Year | -0.20 |
EPS (TTM) | -0.47 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 47.05M | 49.45M | 187.78M | 221.03M |
# of Estimates | 2 | 5 | 5 | 5 |
High Estimate | 47.30M | 51.30M | 190.90M | 233.55M |
Low Estimate | 46.80M | 47.37M | 182.21M | 196.50M |
Year ago Sales | 38.01M | 48.32M | 163.91M | 187.78M |
Year over Year Growth Est. | 23.78% | 2.34% | 14.56% | 17.71% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.11 | -0.09 | -0.39 | -0.20 |
# of Estimates | 5 | 5 | 5 | 5 |
Most Recent Consensus | -0.11 | -0.12 | -0.44 | -0.16 |
High Estimate | -0.09 | -0.06 | -0.34 | -0.08 |
Low Estimate | -0.12 | -0.12 | -0.44 | -0.40 |
Year ago EPS | -0.14 | -0.09 | -0.45 | -0.39 |
Year over Year Growth Est. | 21.43% | 0.00% | 13.33% | 49.74% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.11 | -0.09 | -0.39 | -0.20 |
7 Days Ago | -0.11 | -0.09 | -0.39 | -0.20 |
30 Days Ago | -0.11 | -0.09 | -0.41 | -0.20 |
60 Days Ago | -0.11 | -0.09 | -0.41 | -0.20 |
90 Days Ago | -0.10 | -0.08 | -0.38 | -0.17 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.11 | -0.12 | -0.44 | -0.20 |
Zacks Consensus Estimate | -0.11 | -0.09 | -0.39 | -0.20 |
Earnings ESP | -3.77% | -36.36% | -12.25% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.14 | -0.10 | -0.09 | -0.14 | NA |
Estimate | -0.12 | -0.09 | -0.12 | -0.13 | NA |
Difference | -0.02 | -0.01 | 0.03 | -0.01 | 0.00 |
Surprise | -16.67% | -11.11% | 25.00% | -7.69% | -2.62% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more